Status:

UNKNOWN

A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients

Lead Sponsor:

ALTality, Inc.

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

M.D. Anderson Cancer Center

Conditions:

Pediatric Cancer

Surgery

Eligibility:

All Genders

3-18 years

Phase:

PHASE1

Brief Summary

This is a pilot study to evaluate the feasibility of SpellBound's AR (augmented reality)-enabled scavenger hunt use among 20 pediatric cancer patients undergoing surgery.

Eligibility Criteria

Inclusion

  • Ages 3-18
  • English speaking parents/legal guardians and patients
  • Undergoing major surgery for cancer requiring postoperative hospitalization defined as ≥2 hours of duration of surgery and requiring postoperative hospital admission of at least one night
  • Expected to be prescribed postoperative inpatient opioids
  • Have never taken opioids or have had no daily opioid use within the last 30 days
  • Sufficient cognitive capacity to comprehend and interact with the game. This is defined as ability to utilize mobile technology (use iPad with or without assistance) and activate and respond to AR experiences within the app as determined by the clinician.
  • Both child and a legal guardian are willing and able to provide informed consent.

Exclusion

  • History of documented peripheral neuropathy secondary to cancer treatment
  • Inability to demonstrate an understanding of the game from English instructions
  • Have previous played the ARISETM digital scavenger hunt game
  • Any additional concerns based on the study physicians' assessments

Key Trial Info

Start Date :

January 13 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04674150

Start Date

January 13 2021

End Date

November 30 2021

Last Update

August 16 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

M.D. Anderson Cancer Center

Houston, Texas, United States, 77030

2

Texas Children's Hospital

Houston, Texas, United States, 77030